References
- Efficace F, Bottomley A. Health related quality of life assessment methodology and reported outcomes in randomised controlled trials of primary brain cancer patients. Eur. J. Cancer38, 1824–1831 (2002).
- Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J. Natl Cancer Institute85, 365–376 (1993).
- Taphoorn MJB, Claasssens L, Aaronson NK et al. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur. J. Cancer46, 1033–1040 (2010).
- Taphoorn MJB, Stupp R, Coens C et al. Health-related quality of life in patients with glioblastoma: a randomised controlled trial. Lancet Oncol.6, 937–944 (2005).
- Taphoorn MJB, van den Bent MJ, Mauer ME et al. Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European organisation for research and treatment of cancer randomized clinical trial. J. Clin. Oncol.25, 5723–5730 (2007).
- Weitzner MA, Meyers CA, Gelke CK et al. The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer75, 1151–1161 (1995).
- Klein M, Taphoorn MJ, Heimans JJ et al. Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. J. Clin. Oncol.19, 4037–4047 (2001).
- Keime-Guibert F, Chinot O, Taillandier L et al. Radiotherapy for glioblastoma in the elderly. N. Engl. J. Med.356, 1527–1535 (2007).
- Walker M, Brown J, Brown K et al. Practical problems with the collection and interpretation of serial quality of life assessments in patients with malignant glioma. J. Neurooncol.63, 179–186 (2003).
- Brown PD, Decker PA, Rummans TA et al. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: comparision of patient and caregiver ratings of quality of life. Am. J. Clin. Oncol.31, 163–168 (2008).
- Armstrong TS, Mendoza T, Gning I et al. Validation of the M.D. Anderson symptom inventory brain tumor module (MDASI-BT). J. Neurooncol.80, 27–35 (2006).
- Van den Bent MJ, Wefel SJ, Schiff D et al. Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Neurol.12, 583–593 (2011).
- Douw L, Klein M, Fagel SSAA et al. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol.8, 810–818 (2009).
- Sikkes SAM, de Lange-de Klerk ESM, Pijnenburg YAL et al. A new informant-based questionnaire for instrumental activities of daily living in dementia. Alzheimer Dem.(2012) (In Press).
- Leung A, Lien K, Zeng L et al. The EORTC QLQ-BN20 for assessment of quality of life in patients receiving treatment or prophylaxis for brain metastases: a literature review. Expert Rev. Pharmacoeconomics Outcomes Res.11(6), 693–700 (2011).
- Lien K, Zeng L, Nguyen J et al. FACT-Br for assessment of quality of life in patients receiving treatment for brain metastases: a literature review. Expert Rev. Pharmacoeconomics Outcomes Res.11(6), 701–708 (2011).